These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11952979)

  • 21. Significance of chromosome 22q11 analysis after detection of an increased first-trimester nuchal translucency.
    Hollis B; Mavrides E; Carvalho JS; Hill L; Dickinson V; Thilaganathan B
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):32-4. PubMed ID: 11489222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuchal translucency: association of size and persistence with fetal abnormalities.
    Fukada Y; Yasumizu T; Hoshi K
    Int J Gynaecol Obstet; 2000 Dec; 71(3):281-2. PubMed ID: 11102627
    [No Abstract]   [Full Text] [Related]  

  • 23. First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome.
    Malone FD; Ball RH; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Canick JA; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2005 Aug; 106(2):288-94. PubMed ID: 16055577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
    Josefsson A; Molander E; Selbing A
    Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACOG committee opinion. First-trimester screening for fetal anomalies with nuchal translucency. Number 223, October 1999. Committee on Genetics. American College of Obstetricians and Gynecologists.
    Int J Gynaecol Obstet; 2000 Jan; 68(1):71-2. PubMed ID: 10687844
    [No Abstract]   [Full Text] [Related]  

  • 26. Characteristics and outcome of fetal cystic hygroma diagnosed in the first trimester.
    Graesslin O; Derniaux E; Alanio E; Gaillard D; Vitry F; Quéreux C; Ducarme G
    Acta Obstet Gynecol Scand; 2007; 86(12):1442-6. PubMed ID: 17851808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses.
    Michailidis GD; Economides DL
    Ultrasound Obstet Gynecol; 2001 Feb; 17(2):102-5. PubMed ID: 11251915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
    Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
    Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuchal translucency as an important ultrasound screening tool for the early diagnosis of first trimester chromosomal abnormalities. A preliminary experience.
    Borrelli AL; Borrelli P; Felicetti M; Di Domenico A; Laboccetta A; Torella M
    Minerva Ginecol; 2004 Apr; 56(2):179-80. PubMed ID: 15258549
    [No Abstract]   [Full Text] [Related]  

  • 30. Nuchal translucency in multiple pregnancies.
    Monni G; Zoppi MA; Ibba RM; Putzolu M; Floris M
    Croat Med J; 2000 Sep; 41(3):266-9. PubMed ID: 10962045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
    Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks].
    Markov D; Chernev T; Dimitrova V; Mazneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
    Akush Ginekol (Sofiia); 2004; 43(3):3-10. PubMed ID: 15341249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fetal outcome in nuchal translucency with emphasis on normal fetal karyotype.
    Cha'ban FK; Van Splunder P; Los FJ; Wladimiroff JW
    Prenat Diagn; 1996 Jun; 16(6):537-41. PubMed ID: 8809895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-trimester fetal nuchal translucency thickness and risk for trisomies.
    Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
    Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population.
    Westin M; Saltvedt S; Almström H; Grunewald C; Valentin L
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):150-8. PubMed ID: 17211897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The characteristics of combined genetic screening of the first trimester of pregnancy after use of assisted reproductive technology programs].
    Butenko VL; Bariliak IP; Stefanovich AV
    Tsitol Genet; 2005; 39(1):21-5. PubMed ID: 16018174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
    Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.